Carafate (Sucralfate Oral Suspension) and Hypophosphatemia
Result of checking the interaction of drug Carafate (Sucralfate Oral Suspension) and disease Hypophosphatemia for safety when used together.
When checking interaction based on authoritative sources Drugs.com, Rxlist.com, Webmd.com, Medscape.com there are contraindications or side effects that may cause harm or increase the negative effect from drug use in presence of concomitant diseases.
Consumer:Sucralfate has phosphate binding properties for which the drug is sometimes used therapeutically. However, hypophosphatemia may occur in some patients, regardless of renal status. Therapy with sucralfate should be administered cautiously in patients with preexisting hypophosphatemia. Monitoring phosphate levels in these patients is recommended.
- McCarthy DM "Sucralfate." N Engl J Med 325 (1991): 1017-25
- "Product Information. Carafate (sucralfate)." Hoechst Marion-Roussel Inc, Kansas City, MO.
- Chines A, Pacifici R "Antacid and sucralfate-induced hypophosphatemic osteomalacia: a case report and review of the literature." Calcif Tissue Int 47 (1990): 291-5
Generic Name: sucralfate
Brand Name: Carafate
Synonyms: Carafate